Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ACUTE MYELOGENOUS LEUKEMIA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1912 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bruserud, O
      Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Godder, KT; Henslee-Downey, PJ
      Colony-stimulating factors in stem cell transplantation: Effect on qualityof life

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    3. Uyl-de Groot, CA; Hartog, JGD; Huijgens, PC; Willemze, R; Van Ineveld, BM
      Costs of diagnosis, treatment, and follow up of patients with acute myeloid leukemia in the Netherlands

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    4. Grimwade, D
      The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    5. Kearney, L
      Molecular cytogenetics

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    6. Mrozek, K; Heinonen, K; Bloomfield, CD
      Clinical importance of cytogenetics in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    7. Dash, A; Gilliland, DG
      Molecular genetics of acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    8. Lowenberg, B
      Prognostic factors in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    9. Langmuir, PB; Aplenc, R; Lange, BJ
      Acute myeloid leukaemia in children

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    10. Burnett, AK
      Treatment of acute myeloid leukaemia in younger patients

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    11. Dann, EJ; Rowe, JM
      Biology and therapy of secondary leukaemias

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    12. Buchner, T; Hiddemann, W; Schoch, C; Haferlach, T; Sauerland, MC; Heinecke, A
      Acute myeloid leukaemia (AML): treatment of the older patient

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    13. Estey, EH
      Growth factors in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    14. Sonneveld, P; List, AF
      Chemotherapy resistance in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    15. Agarwala, SS; Sabbagh, MH
      Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment

      EXPERT OPINION ON BIOLOGICAL THERAPY
    16. Sievers, EL
      Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse

      EXPERT OPINION ON BIOLOGICAL THERAPY
    17. Timmermann, S; Lehrmann, H; Polesskaya, A; Harel-Bellan, A
      Histone acetylation and disease

      CELLULAR AND MOLECULAR LIFE SCIENCES
    18. Snider, JV; Wechser, MA; Lossos, IS
      Human disease characterization: real-time quantitative PCR analysis of gene expression

      DRUG DISCOVERY TODAY
    19. Frankel, AE; Schuster, MW; Jurcic, JG
      Novel therapeutics for chemotherapy-resistant acute myeloid leukaemia

      BIODRUGS
    20. Bruserud, O; Foss, B; Petersen, H
      Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L)

      EUROPEAN CYTOKINE NETWORK
    21. Hansen, CM; Binderup, L; Hamberg, KJ; Carlberg, C
      Vitamin D and cancer: Effects of 1,25(OH)(2)D-3 and its analogs on growth control and tumorigenesis

      FRONTIERS IN BIOSCIENCE
    22. Thomas, JG; Olson, JM; Tapscott, SJ; Zhao, LP
      An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles

      GENOME RESEARCH
    23. Friedberg, JW; Neuberg, D; Monson, J; Jallow, H; Nadler, LM; Freedman, AS
      The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    24. Cao, TM; Horning, SF; Negrin, RS; Hu, WW; Johnston, LF; Taylor, TL; Shizuru, JA; Hoppe, RT; Brown, BW; Blume, KG; Stockerl-Goldstein, K
      High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: The Stanford University experience

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    25. Pabst, T; Mueller, BU; Harakawa, N; Schoch, C; Haferlach, T; Behre, G; Hiddemann, W; Zhang, DE; Tenen, DG
      AML1-ETO downregulates the granulocytic differentiation factor C/EBP alphain t(8;21) myeloid leukemia

      NATURE MEDICINE
    26. Gore, SD; Weng, LJ; Zhai, S; Figg, WD; Donehower, RC; Dover, GJ; Grever, M; Griffin, CA; Grochow, LB; Rowinsky, EK; Zabalena, Y; Hawkins, EK; Burks, K; Miller, CB
      Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia

      CLINICAL CANCER RESEARCH
    27. Taub, JW
      Relationship of chromosome 21 and acute leukemia in children with Down syndrome

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    28. Shearer, P; Kapoor, G; Beckwith, JB; Takashima, J; Breslow, N; Green, DM
      Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors: A report from the National Wilms Tumor Study Group

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    29. Monteleone, PM; Steele, DA; King, AK; Konefal, S; Kelleher, JF
      Bilateral breast relapse in acute myelogenous leukemia

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    30. McDermott, MB; Corbally, MT; O'Marcaigh, AS
      Extracutaneous Sweet syndrome involving the gastrointestinal tract in a patient with Fanconi anemia

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    31. Bruserud, O; Gjertsen, BT; Foss, B; Huang, TS
      New strategies in the treatment of acute myelogenous leukemia (AML): In vitro culture of AML cells - The present use in experimental studies and the possible importance for future therapeutic approaches

      STEM CELLS
    32. Balducci, L; Hardy, CL; Lyman, GH
      Hematopoietic growth factors in the older cancer patient

      CURRENT OPINION IN HEMATOLOGY
    33. Holdsworth, MT; Mathew, P
      Efficacy of colony-stimulating factors in acute leukemia

      ANNALS OF PHARMACOTHERAPY
    34. Gaur, AH; Patrick, CC; McCullers, JA; Flynn, PM; Pearson, TA; Razzouk, BI; Thompson, SJ; Shenep, JL
      Bacillus cereus bacteremia and meningitis in immunocompromised children

      CLINICAL INFECTIOUS DISEASES
    35. Sohal, J; Chase, A; Mould, S; Corcoran, M; Oscier, D; Iqbal, S; Parker, S; Welborn, J; Harris, RI; Martinelli, G; Montefusco, V; Sinclair, P; Wilkins, BS; van den Berg, H; Vanstraelen, D; Goldman, JM; Cross, NCP
      Identification of four new translocations involving FGFRI in myeloid disorders

      GENES CHROMOSOMES & CANCER
    36. Jamal, R; Taketani, T; Taki, T; Bessho, F; Hongo, T; Hamaguchi, H; Horiike, S; Taniwaki, M; Hanada, R; Nakamura, H; Hayashi, Y
      Coduplication of the MLL and FLT3 genes in patients with acute myeloid leukemia

      GENES CHROMOSOMES & CANCER
    37. Andersen, MK; Christiansen, DH; Kirchhoff, M; Pedersen-Bjergaard, J
      Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents

      GENES CHROMOSOMES & CANCER
    38. Rudin, CM; Thompson, CB
      Transcriptional activation of short interspersed elements by DNA-damaging agents

      GENES CHROMOSOMES & CANCER
    39. Stein, RS; Wolff, SN; Greer, JP; Flexner, JM; Goodman, S; Jagasia, M; Brandt, SJ; Morgan, DS; Arrowsmith, E; McCurley, TL
      Age and cytogenetics as predictors of event free survival in patients withacute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy

      LEUKEMIA & LYMPHOMA
    40. Somjee, S; Borker, A; Gardner, R; Velez, MC
      Multiple granulocytic sarcomas in acute myeloblastic leukemia with simultaneous occurrence of t(8 : 21) and trisomy 8

      LEUKEMIA & LYMPHOMA
    41. Barragan, E; Bolufer, P; Moreno, I; Martin, G; Nomdedeu, J; Brunet, S; Fernandez, P; Rivas, C; Sanz, MA
      Quantitative detection of AML1-ETO rearrangement by real-time RT-PCR usingfluorescently labeled probes

      LEUKEMIA & LYMPHOMA
    42. Allan, DS; Buckstein, R; Imrie, KR
      Outpatient supportive care following chemotherapy for acute myeloblastic leukemia

      LEUKEMIA & LYMPHOMA
    43. Hartmann, F; Jacobs, G; Gotto, H; Schwamborn, J; Pfreundschuh, M
      Cytosine arabinoside, idarubicin and divided dose etoposide for the treatment of acute myeloid leukemia in elderly patients

      LEUKEMIA & LYMPHOMA
    44. Mori, M; Hatake, K; Tanaka, M; Takatoku, M; Matsumoto, Y; Uchida, M; Kametaka, N; Nagai, T; Terui, Y; Tomizuka, H; Muroi, K; Ozawa, K
      CAM-cytarabine, aclarubicin plus macrophage colony-stimulating factor in the treatment of acute myelogenous leukemia with trilineage dysplasia: Usefulness of in vitro apoptosis in leukemic cells

      LEUKEMIA & LYMPHOMA
    45. Invernizzi, R; Pecci, A; Bellotti, L; Ascari, E
      Expression of p53, bcl-2 and ras oncoproteins and apoptosis levels in acute leukaemias and myelodysplastic syndromes

      LEUKEMIA & LYMPHOMA
    46. Jourdan, E; Reiffers, J; Stoppa, AM; Sotto, JJ; Attal, M; Bouabdallaha, R; Marit, G; Fegueux, N; Boulat, O; Dastugue, N; Boiron, JM; Faberes, C; Gastaut, JA; Maraninchi, D; Blaise, D
      Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT study group

      LEUKEMIA & LYMPHOMA
    47. Giles, FJ; Shen, Y; Kantarjian, HM; Korbling, MJ; O'Brien, S; Anderlini, P; Donato, M; Pierce, S; Keating, MJ; Freireich, EJ; Estey, E
      Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long term survival

      LEUKEMIA & LYMPHOMA
    48. Leone, G; Voso, MT; Sica, S; Morosetti, R; Pagano, L
      Therapy related leukemias: Susceptibility, prevention and treatment

      LEUKEMIA & LYMPHOMA
    49. Vidarsson, B; Abonour, R; Williams, EC; Woodson, RD; Turman, NJ; Kim, K; Mosher, DF; Wiersma, SR; Longo, WL
      Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia

      LEUKEMIA & LYMPHOMA
    50. Preisler, HD; Venugopal, P; Gregory, SA; Adler, S; Gezer, S; Hsu, WT; Manson, S; Larson, A; Jajeh, A; Slvinick, D; Galvez, A
      High remission rate in acute myeloblastic leukemia with only two days of chemotherapy

      LEUKEMIA & LYMPHOMA
    51. Tao, M; Li, BR; Nayini, J; Sivaraman, S; Song, SW; Larson, A; Toofanfard, M; Chen, H; Venugopal, P; Preisler, HD
      In vivo effects of IL-4, IL-10, and amifostine on cytokine production in patients with acute myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    52. Faderl, S; Estrov, Z
      The clinical significance of caspase regulation in acute leukemia

      LEUKEMIA & LYMPHOMA
    53. Wheeler, C; Khurshid, A; Ibrahim, J; Elias, A; Mauch, P; Ault, K; Antin, J
      Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV)

      LEUKEMIA & LYMPHOMA
    54. Baldus, C; Fietz, T; Rieder, H; Schwartz, S; Thiel, E; Knauf, W
      MDR-1 expression and deletions of chromosomes 7 and 5(Q) separately indicate adverse prognosis in AML

      LEUKEMIA & LYMPHOMA
    55. Carella, AM; Cascavilla, N; Greco, MM; Melillo, L; Sajeva, MR; Ladogana, S; D'Arena, G; Perla, G; Carotenuto, M
      Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (FLAG regimen): A single center study

      LEUKEMIA & LYMPHOMA
    56. Clavio, M; Gatto, S; Beltrami, G; Cerri, R; Carrara, P; Pierri, I; Canepa, L; Miglino, M; Balleari, E; Masoudi, B; Damasio, E; Ghio, R; Sessarego, M; Gobbi, M
      First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia

      LEUKEMIA & LYMPHOMA
    57. Russo, D; Pricolo, G; Michieli, M; Michelutti, A; Raspadori, D; Bertone, A; Marin, L; Pierri, I; Bucalossi, A; Zuffa, E; De Vivo, A; Mazza, P; Gobbi, M; Lauria, F; Zaccaria, A; Baccarani, M
      Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia

      LEUKEMIA & LYMPHOMA
    58. Bohgaki, T; Notoya, A; Kondo, M; Mukai, M; Kohno, M
      Leukemia cutis in an elderly patient treated with low dose cytosine arabinoside and etoposide

      LEUKEMIA & LYMPHOMA
    59. Sievers, EL; Linenberger, M
      Mylotarg: antibody-targeted chemotherapy comes of age

      CURRENT OPINION IN ONCOLOGY
    60. Berdeja, JG; Flinn, IW
      New approaches to blood and marrow transplantation for patients with low-grade lymphomas

      CURRENT OPINION IN ONCOLOGY
    61. Pinto, A; Zagonel, V; Ferrara, F
      Acute myeloid leukemia in the elderly: biology and therapeutic strategies

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    62. Jurcic, JG
      Antibody therapy for residual disease in acute myelogenous leukemia

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    63. Kleef, R; Jonas, WB; Knogler, W; Stenzinger, W
      Fever, cancer incidence and spontaneous remissions

      NEUROIMMUNOMODULATION
    64. Nishikawa, M; Yamamoto, M; Watanabe, Y; Kita, K; Shiku, H
      Clinical significance of low protein phosphatase-1 activity of blasts in acute myelogenous leukemia with high white cell counts

      INTERNATIONAL JOURNAL OF ONCOLOGY
    65. Sonneveld, P
      Multidrug resistance in haematological malignancies (Reprinted from Journal of Internal Medicine, vol 247, pg 521-534, 2000)

      JOURNAL OF INTERNAL MEDICINE
    66. Fukuyama, T; Sueoka, E; Sugio, Y; Otsuka, T; Niho, Y; Akagi, K; Kozu, T
      MTG8 proto-oncoprotein interacts with the regulatory subunit of type II cyclic AMP-dependent protein kinase in lymphocytes

      ONCOGENE
    67. Licht, JD
      AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML

      ONCOGENE
    68. Niitsu, N; Hayashi, Y; Honma, Y
      Downregulation of MLL-CBP fusion gene expression is associated with differentiation of SN-1 cells with t(11;16)(q23;p13)

      ONCOGENE
    69. Verbeek, W; Ganser, A
      Evolving treatment options of myelodysplastic syndromes

      ANNALS OF HEMATOLOGY
    70. Kern, W; Schleyer, E; Braess, J; Wittmer, E; Ohnesorge, J; Unterhalt, M; Wormann, B; Buchner, T; Hiddemann, W
      Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone [FIS-HAM] salvage therapy in highly resistant acuteleukemias

      ANNALS OF HEMATOLOGY
    71. Castagnola, C; Alessandrino, EP; Lunghi, M; Bernasconi, P; Della Porta, M; Mangiacavalli, S; Colombo, A; Corso, A; Pagnucco, G; Lazzarino, M; Bernasconi, C
      Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: a single center experience

      ANNALS OF HEMATOLOGY
    72. Neumeister, P; Eibl, M; Zinke-Cerwenka, W; Scarpatetti, M; Sill, H; Linkesch, W
      Hepatic veno-occlusive disease in two patients with relapsed acute myeloidleukemia treated with anti-CD33 calicheamicin (CMA-676) immunoconjugate

      ANNALS OF HEMATOLOGY
    73. Voog, E; Le, QL; Philip, I; Benetaib, B; Michallet, M; Fiere, D; Thomas, X
      Autologous transplantation in acute myeloid leukemia: peripheral blood stem cell harvest after mobilization in steady state by granulocyte colony-stimulating factor alone

      ANNALS OF HEMATOLOGY
    74. von Lilienfeld-Toal, M; Ebert, O; Theuerkauf, I; Glasmacher, A; Schmidt-Wolf, IGH
      Small bowel obstruction in acute myelogenous leukemia: stenosis or paralysis?

      ANNALS OF HEMATOLOGY
    75. Lorsbach, RB; Downing, JR
      The role of the AML1 transcription factor in leukemogenesis

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    76. Fukushima, T; Yamashita, T; Goto, N; Ueda, T; Okabe, K; Kuraishi, Y; Ohno, R; Urabe, A; Ogawa, M
      A pharmacokinetic study of idarubicin in Japanese patients with malignant lymphoma: Relationship with leukocytopenia and neutropenia

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    77. Fukuno, K; Tsurumi, H; Yoshikawa, T; Yamada, T; Oyama, M; Moriwaki, H
      A variant form of acute promyelocytic leukemia with marked myelofibrosis

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    78. Shimohakamada, Y; Shinohara, K; Fukuda, N
      Remission of acute myeloblastic leukemia after severe pneumonia treated with high-dose methylprednisolone

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    79. Kakazu, N; Shinzato, I; Arai, Y; Gotoh, S; Matsushita, A; Ishikawa, T; Nagai, K; Takahashi, T; Ohno, T; Tsuchiya, T; Ohki, M; Abe, T
      Involvement of the NUP98 gene in a chromosomal translocation t(11;20)(p15;q11.2) in a patient with acute monocytic leukemia (FAB-M5b)

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    80. Cha, KE; Yoon, SY; Lee, KN
      Effect of granulocyte colony-stimulating factor on chemotherapeutic activity of cytosine arabinoside in acute leukemic cell lines

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    81. Kobayashi, R; Arioka, E; Yoshida, M; Cho, Y; Iguchi, A; Kaneda, M; Shikano, T
      Prolonged bone marrow failure with monosomy 7 after engraftment failure following bone marrow transplantation

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    82. Ishiga, K; Kawatani, T; Suou, T; Tajima, F; Omura, H; Idobe, Y; Kawasaki, H
      Fulminant hepatitis type B after chemotherapy in a serologically negative hepatitis B virus carrier with acute myelogenous leukemia

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    83. Yamauchi, T; Kawai, Y; Kishi, S; Goto, N; Urasaki, Y; Imamura, S; Fukushima, T; Yoshida, A; Iwasaki, H; Tsutani, H; Masada, M; Ueda, T
      Monitoring of intracellular 1-beta-D-arabinofuranosylcytosine 5 '-triphosphate in 1-beta-D-arabinofuranosylcytosine therapy at low and conventional doses

      JAPANESE JOURNAL OF CANCER RESEARCH
    84. Spiekermann, K; Biethahn, S; Wilde, S; Hiddemann, W; Alves, F
      Constitutive activation of STAT transcription factors in acute myelogenousleukemia

      EUROPEAN JOURNAL OF HAEMATOLOGY
    85. Lehmann, S; Bengtzen, S; Paul, A; Christensson, B; Paul, C
      Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance

      EUROPEAN JOURNAL OF HAEMATOLOGY
    86. Foss, B; Ulvestad, E; Bruserud, O
      Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia:PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts

      EUROPEAN JOURNAL OF HAEMATOLOGY
    87. Norgaard, JM; Langkjer, ST; Palshof, T; Pedersen, B; Hokland, P
      Pretreatment leukaemia cell drug resistance is correlated to clinical outcome in acute myeloid leukaemia

      EUROPEAN JOURNAL OF HAEMATOLOGY
    88. Horowitz, MM; Loberiza, FR; Bredeson, CN; Rizzo, JD; Nugent, ML
      Transplant registries: Guiding clinical decisions and improving outcomes

      ONCOLOGY-NEW YORK
    89. Perentesis, JP; Sievers, EL
      Targeted therapies for high-risk acute myeloid leukemia

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    90. Kratz, CP; Emerling, BM; Donovan, S; Laig-Webster, M; Taylor, BR; Thompson, P; Jensen, S; Banerjee, A; Bonifas, J; Makalowski, W; Green, ED; Le Beau, MM; Shannon, KM
      Candidate gene isolation and comparative analysis of a commonly deleted segment of 7q22 implicated in myeloid malignancies

      GENOMICS
    91. Biagi, E; Rovelli, A; De Lorenzo, P; Uderzo, C
      Autologous hematopoietic stem cell transplantation (AHSCT) as consolidation therapy for childhood acute myelogenous leukemia in 1st complete remission

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    92. Markaki, EA; Tsopanomichalou, M; Dimitriou, H; Stiakaki, E; Perdikoyanni, C; Spandidos, D; Kalmanti, M
      Mutations of retinoblastoma gene (Rb-1) as a prognostic factor in childrenwith acute leukemia and neuroblastoma

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    93. Razzouk, BI; Raimondi, SC; Srivastava, DK; Pritchard, M; Behm, FG; Tong, X; Sandlund, JT; Rubnitz, JE; Pui, CH; Ribeiro, RC
      Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience

      LEUKEMIA
    94. Bradstock, K; Matthews, J; Young, G; Lowenthal, R; Baxter, H; Arthur, C; Bashford, J; Brighton, T; Cannell, P; Dunlop, L; Durrant, S; Enno, A; Eliadis, P; Gill, D; Gillett, A; Gottlieb, D; Januszewicz, H; Joshua, D; Leahy, M; Schwarer, A; Taylor, K
      Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia

      LEUKEMIA
    95. Varella-Garcia, M; Hogan, CJ; Odom, LF; Murata-Collins, JL; Ai, H; Chen, L; Richkind, K; Paskulin, C; Andreeff, M; Brizard, A; McGavran, L; Gemmill, RM; Berger, R; Drabkin, HA
      Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34(+) cell sorting

      LEUKEMIA
    96. Rombouts, WJC; Lowenberg, B; van Putten, WLJ; Ploemacher, RE
      Improved prognostic significance of cytokine-induced proliferation in vitro in patients with de novo acute myeloid leukemia of intermediate risk: impact of internal tandem duplications in the Flt3 gene

      LEUKEMIA
    97. Marcucci, G; Caligiuri, MA; Dohner, H; Archer, KJ; Schlenk, RF; Dohner, K; Maghraby, EA; Bloomfield, CD
      Quantification of CBF beta/MYH11 fusion transcript by Real Time RT-PCR in patients with INV(16) acute myeloid leukemia

      LEUKEMIA
    98. Galmarini, CM; Mackey, JR; Dumontet, C
      Nucleoside analogues: mechanisms of drug resistance and reversal strategies

      LEUKEMIA
    99. Visani, G; Bernasconi, P; Boni, M; Castoldi, GL; Ciolli, S; Clavio, M; Cox, MC; Cuneo, A; Del Poeta, G; Dini, D; Falzetti, D; Fanin, R; Gobbi, M; Isidori, A; Leoni, F; Liso, V; Malagola, M; Martinelli, G; Mecucci, C; Piccaluga, PP; Petti, MC; Rondelli, R; Russo, D; Sessarego, M; Specchia, G; Testoni, N; Torelli, G; Mandelli, F; Tura, S
      The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia - analysis of 848 patients

      LEUKEMIA
    100. Visani, G; Milligan, D; Leoni, F; Chang, J; Kelsey, S; Marcus, R; Powles, R; Schey, S; Covelli, A; Isidori, A; Litchman, M; Piccaluga, PP; Mayer, H; Malagola, M; Pfister, C
      Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia

      LEUKEMIA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/05/20 alle ore 07:58:56